List With HCPCS Codes For Cancer and Vision Associated Drugs

The HCPCS codes for Cancer and Vision Associated Drugs Q5112-Q5132 are used to identify specific drugs used in the treatment of cancer and vision-related conditions.

1. HCPCS Code Q5112

HCPCS Q5112 describes the injection of trastuzumab-dttb, a biosimilar medication known as Ontruzant, which is used in the treatment of certain types of breast cancer.

2. HCPCS Code Q5113

HCPCS Q5113 describes the injection of trastuzumab-pkrb, a biosimilar medication known as Herzuma, which is used in the treatment of certain types of breast cancer.

3. HCPCS Code Q5114

HCPCS Q5114 describes the injection of trastuzumab-dkst, a biosimilar medication known as Ogivri, which is used in the treatment of certain types of breast cancer.

4. HCPCS Code Q5115

HCPCS Q5115 describes the injection of rituximab-abbs, a biosimilar medication known as Truxima, which is used in the treatment of certain types of cancer, including non-Hodgkin’s lymphoma.

5. HCPCS Code Q5116

HCPCS Q5116 describes the injection of trastuzumab-qyyp, a biosimilar medication known as trazimera, which is used in the treatment of certain types of breast cancer.

6. HCPCS Code Q5117

HCPCS Q5117 describes the injection of trastuzumab-anns, a biosimilar medication known as kanjinti, which is used in the treatment of certain types of breast cancer.

7. HCPCS Code Q5118

HCPCS Q5118 describes the injection of bevacizumab-bvzr, a biosimilar medication known as Zirabev, which is used in the treatment of various types of cancer, including colorectal, lung, and kidney cancer.

8. HCPCS Code Q5119

HCPCS Q5119 describes the injection of rituximab-pvvr, a biosimilar medication known as ruxience, which is used in the treatment of certain types of cancer, including non-Hodgkin’s lymphoma.

9. HCPCS Code Q5120

HCPCS Q5120 describes the injection of pegfilgrastim-bmez, a biosimilar medication known as ziextenzo, which is used to stimulate the production of white blood cells in cancer patients undergoing chemotherapy.

10. HCPCS Code Q5121

HCPCS Q5121 describes the injection of infliximab-axxq, a biosimilar medication known as avsola, which is used in the treatment of certain autoimmune diseases, including rheumatoid arthritis and Crohn’s disease.

11. HCPCS Code Q5122

HCPCS Q5122 describes the injection of pegfilgrastim-apgf, a biosimilar medication known as nyvepria, which is used to stimulate the production of white blood cells in cancer patients undergoing chemotherapy.

12. HCPCS Code Q5123

HCPCS Q5123 describes the injection of rituximab-arrx, a biosimilar medication known as riabni, which is used in the treatment of certain types of cancer, including non-Hodgkin’s lymphoma.

13. HCPCS Code Q5124

HCPCS Q5124 describes the injection of ranibizumab-nuna, a biosimilar medication known as byooviz, which is used in the treatment of certain eye conditions, including age-related macular degeneration.

14. HCPCS Code Q5125

HCPCS Q5125 describes the injection of filgrastim-ayow, a biosimilar medication known as releuko, which is used to stimulate the production of white blood cells in cancer patients undergoing chemotherapy.

15. HCPCS Code Q5126

HCPCS Q5126 describes the injection of bevacizumab-maly, a biosimilar medication known as alymsys, which is used in the treatment of various types of cancer, including colorectal, lung, and kidney cancer.

16. HCPCS Code Q5127

HCPCS Q5127 describes the injection of pegfilgrastim-fpgk, a biosimilar medication known as stimufend, which is used to stimulate the production of white blood cells in cancer patients undergoing chemotherapy.

17. HCPCS Code Q5128

HCPCS Q5128 describes the injection of ranibizumab-eqrn, a biosimilar medication known as cimerli, which is used in the treatment of certain eye conditions, including age-related macular degeneration.

18. HCPCS Code Q5129

HCPCS Q5129 describes the injection of bevacizumab-adcd, a biosimilar medication known as vegzelma, which is used in the treatment of various types of cancer, including colorectal, lung, and kidney cancer.

19. HCPCS Code Q5130

HCPCS Q5130 describes the injection of pegfilgrastim-pbbk, a biosimilar medication known as fylnetra, which is used to stimulate the production of white blood cells in cancer patients undergoing chemotherapy.

20. HCPCS Code Q5131

HCPCS Q5131 describes the injection of adalimumab-aacf, a biosimilar medication known as idacio, which is used in the treatment of various autoimmune diseases, including rheumatoid arthritis and psoriasis.